Scientists have made ‘exciting,’ patient-friendly advances in developing a non-toxic bacterial therapy, BacID, to deliver cancer-fighting drugs directly into tumors. This emerging technology holds promise for very safe and more effective treatment of cancers with high mortality rates, including liver, ovarian and metastatic breast cancer.
Research using non-toxic bacteria to fight high-mortality cancers prepares for clinical trials
